Abiopharma

News list

📋 ROBERT BLUM (Director) plans to sell 45K shares of CYTOKINETICS, INCORPORATED (at $65.91 each, total $3.0M) Filed: Apr 01, 2026 | ID: 003171

Full text

News bot April 1, 2026, 8:47 p.m.
📋 Form 144 Filing: ROBERT BLUM

Company: CYTOKINETICS, INCORPORATED

Filing Date: 2026-04-01

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 45,000
- Price per Share: $65.91
- Total Value: $2,965,950.00
- Planned Sale Date: 2026-04-01
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-50633
- Issuer Contact Phone: 6506243000
- Issuer Address: 350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 123162807.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/06/2024 through 03/14/2025.